LQDA (LQDA) Stock Price & Analysis
LQDA (LQDA) fell 1.43% to USD 67.68 as of September 8, 2026 at 20:11 UTC, according to Nexqual real-time market data.
LQDA last closed at USD 67.68; the session ranged USD 67.07–69.21 on volume of 1,279,458 shares. Market capitalization is —, with a 52-week range of USD 21.15–93.61 (NCM). Source: Nexqual, September 8, 2026 at 20:11 UTC.
Key Statistics (as of September 8, 2026 at 20:11 UTC)
| Price | USD 67.68 |
|---|---|
| Change | ▼ 1.43% (down) |
| Previous Close | USD 67.68 |
| Open | USD 67.68 |
| Day Range | USD 67.07 – 69.21 |
| 52-Week Range | USD 21.15 – 93.61 |
| Volume | 1,279,458 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (LQDA)
Nexqual's technical model rates LQDA "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 20:11 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.8 (neutral) |
| vs SMA50 | Below (USD 78.28) |
| MACD | -3.26 (negative) |
From LQDA's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
| KNSA | Kiniksa Pharmaceuticals Interna | USD 77.09 | ▼ 4.2% |
| MIRM | Mirum Pharmaceuticals, Inc. | USD 99.53 | ▼ 1.09% |
| PTGX | Protagonist Therapeutics, Inc. | USD 145.94 | ▼ 1.92% |
| SRRK | Scholar Rock Holding Corporatio | USD 57.42 | ▲ 2.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 20:11 UTC. This page is informational and not investment advice.